cdmo.directory
← Compare landing

Altruist Biologics vs Capitol Biologics

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/altruist-biologics/capitolbiologics

CategoryAltruist BiologicsCapitol Biologics
Listed sitecdmocdmo
SummaryGlobal CDMO offering end-to-end development and GMP manufacturing for monoclonal antibodies, bispecific antibodies, fusion proteins, recombinant proteins, and antibody-drug conjugates, with facilities in Suzhou and Hangzhou featuring up to 20,000-liter bioreactors.Capitol Biologics is a full-service CDMO supporting R&D and early-phase clinical trial manufacturing for emerging biotech firms. It focuses on biologics, proteins, and monoclonal antibodies from cell line development through GMP manufacturing.
Services
  • Cell-Line Development
  • Process Development
  • Formulation Development
  • CMC Analytical Development
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • Bioconjugation Services
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • CMC Regulatory Submission Support
  • Secondary Packaging & Labeling
  • Cell-Line Development
  • Process Development
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • Formulation Development
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
Modalities
  • Biologics (Monoclonal Antibodies)
  • Antibody-Drug Conjugate (ADC)
  • Biologics (Other)
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
IndicationsData not yet provided.Data not yet provided.
Locations
  • Suzhou, Suzhou, China
  • Hangzhou, Hangzhou, China
  • Frederick, Frederick, MD, US
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.